PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 44 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

6 May 2025

  1. (diff | hist) 16:44 Talk:Lyophilisation 748 +252 ColdChainCleo (talk | contribs) /* Vapour-pressure table: source and rounding */ reply
  2. (diff | hist) 14:18 Talk:Lyophilisation 537 +349 SigFigSindri (talk | contribs) /* Vapour-pressure table: source and rounding */ new section
  3. (diff | hist) 13:58 Talk:Area percent purity 885 +210 AnalyticalAnnie (talk | contribs) /* Should the four unseen categories be a definition list? */ reply
  4. (diff | hist) 11:43 Cost per milligram 3,122 ±0 Peptide_Pete (talk | contribs) add the harm-reduction cross-link [rollback]
  5. (diff | hist) m 11:30 Lot traceability 4,028 +26 AttributeAnders (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]
  6. (diff | hist) 10:22 Talk:Area percent purity 674 +200 StyleSheetSybil (talk | contribs) /* Should the four unseen categories be a definition list? */ new section
  7. (diff | hist) 09:36 Peptide harm reduction 3,975 +507 HarmReductionHen (talk | contribs) fix a dangling clause [rollback]
  8. (diff | hist) 05:19 Multi-dose vial 14,969 +2,480 SecondarySrc_Seb (talk | contribs) copyedit [rollback]
  9. (diff | hist) 03:06 Growth hormone secretagogue 3,620 ±0 SecretagogueSol (talk | contribs) add the molecular weight, calculated from the sequence and stated as such [rollback]
  10. (diff | hist) 03:00 Glucagon-like peptide-1 11,229 +977 BPC_Bramwell (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  11. (diff | hist) m 02:35 Gastric emptying 4,652 +16 EndotoxinEd (talk | contribs) expand §Normal physiology [rollback]
  12. (diff | hist) m b 02:13 Shanghai Wibson Biotechnology 7,557 +1,145 StubSorterBot (talk | contribs) bot: add supplier category [rollback]
  13. (diff | hist) 00:13 PeptideMeter 3,902 +29 GroupBuyGalen (talk | contribs) de-orphan [rollback]

5 May 2025

  1. (diff | hist) 20:42 USP General Chapter 71 3,363 ±0 eGFR_Esme (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  2. (diff | hist) m 19:23 Personal importation policy 3,251 ±0 MassSpecMarv (talk | contribs) clarify the difference between a marketing authorisation and a registration [rollback]
  3. (diff | hist) 17:33 GLP-1 receptor agonist 9,758 +504 PurityClaimPia (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  4. (diff | hist) 14:28 Trifluoroacetate counterion 3,899 ±0 KarlFischerKit (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  5. (diff | hist) m 11:10 Guangzhou JEEP Biotechnology 11,389 ±0 GroupBuyGalen (talk | contribs) fix the anchor on an internal link [rollback]
  6. (diff | hist) 09:05 Orforglipron 4,505 +40 LiraLotte (talk | contribs) label the animal data as animal data in the sentence, not only in the section heading [rollback]
  7. (diff | hist) 08:49 Talk:Hubei Jianxiang Bioscience 1,033 +134 SupplyWatchSuri (talk | contribs) /* Dispatch address versus registered address */ reply
  8. (diff | hist) m 06:28 Sterile water for injection 4,413 +794 SurvodutideSaff (talk | contribs) expand §Compendial requirements [rollback]
  9. (diff | hist) m b 04:37 Adverse effects of GLP-1 receptor agonists 5,314 +17 CategoryBot (talk | contribs) bot: add maintenance category [rollback]
  10. (diff | hist) 01:17 Underfilling 3,432 ±0 SelectTrialSam (talk | contribs) split §What a report shows from §What it does not [rollback]

4 May 2025

  1. (diff | hist) m 20:35 Global access disparity 3,314 +114 CheckSumChase (talk | contribs) add the harm-reduction cross-link [rollback]
  2. (diff | hist) m 16:22 FLOW trial 3,481 ±0 AppendixAlva (talk | contribs) add the PMID [rollback]
  3. (diff | hist) 14:07 Blind sampling 6,780 ±0 UnderfillUna (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  4. (diff | hist) 13:53 USP General Chapter 85 4,270 ±0 ApoB_Aurelio (talk | contribs) add the note on co-elution and what it hides [rollback]
  5. (diff | hist) 13:32 Residual solvent 4,125 ±0 Areapercent_Ayo (talk | contribs) fix the anchor on an internal link [rollback]
  6. (diff | hist) m 10:34 Sarcopenia 3,713 +273 Ref_Desk_Ron (talk | contribs) clarify that the marker is method-dependent and not comparable across platforms [rollback]
  7. (diff | hist) 03:50 Contract development and manufacturing organisation 4,216 +412 FreightFenna (talk | contribs) expand §Consequences for reading documentation [rollback]

3 May 2025

  1. (diff | hist) 20:24 Arcuate nucleus 4,321 ±0 TimelineTiernan (talk | contribs) expand §Neuronal populations [rollback]
  2. (diff | hist) m b 19:40 WuXi TIDES 11,344 +673 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  3. (diff | hist) 18:25 Exenatide 4,449 ±0 IncretinIvo (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  4. (diff | hist) m 13:48 Haemoglobin A1c 3,396 +30 RegainRomilly (talk | contribs) clarify that the marker is method-dependent and not comparable across platforms [rollback]
  5. (diff | hist) 12:25 Chinese Peptide Company 11,801 +968 ChainCustodyChad (talk | contribs) add the transit window each regional warehouse serves [rollback]
  6. (diff | hist) m b 11:39 Reference standard 4,154 ±0 CategoryBot (talk | contribs) bot: flag bare reference [rollback]
  7. (diff | hist) m b 10:27 Amino acid analysis 4,038 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) 09:26 Talk:Hubei Jianxiang Bioscience 822 +182 NPOV_Nadia (talk | contribs) /* Dispatch address versus registered address */ reply
  9. (diff | hist) m 07:30 Xi'an Mokemei Biotechnology 5,092 +335 LabRangeLindy (talk | contribs) state the city and province of the registered address [rollback]
  10. (diff | hist) m b 07:25 Fmoc chemistry 4,430 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  11. (diff | hist) m 06:12 Proglucagon 5,743 ±0 GIP_Genoveva (talk | contribs) add the postprandial time course with its units [rollback]

2 May 2025

  1. (diff | hist) 22:48 MOTS-c 3,340 +30 MissedDoseMik (talk | contribs) state which receptor subtype the binding data refers to [rollback]
  2. (diff | hist) 21:02 Fasting insulin 3,216 ±0 ResolutionRoo (talk | contribs) expand §Standardisation [rollback]
  3. (diff | hist) 19:25 TRIUMPH trial programme 4,014 ±0 ProglucagonPia (talk | contribs) ce per PP:MOS [rollback]
  4. (diff | hist) 13:44 Talk:Hubei Jianxiang Bioscience 611 +202 CustomsClarke (talk | contribs) /* Dispatch address versus registered address */ reply
  5. (diff | hist) 13:42 Temperature excursion 5,809 +1,019 SupplyWatchSuri (talk | contribs) expand §Quantifying an excursion [rollback]
  6. (diff | hist) 12:23 Shanghai Sigma-Audley New Material Technology 8,895 +602 Peptide_Pete (talk | contribs) expand §External links [rollback]
  7. (diff | hist) 10:11 Talk:Hubei Jianxiang Bioscience 400 +354 SupplyWatchSuri (talk | contribs) /* Dispatch address versus registered address */ new section
  8. (diff | hist) 09:57 Dulaglutide 4,161 ±0 Areapercent_Ayo (talk | contribs) de-duplicate a repeated sentence [rollback]
  9. (diff | hist) m 07:48 Chain of custody 4,085 ±0 BatchNumberBede (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]

1 May 2025

  1. (diff | hist) 20:44 Semaglutide 8,560 +481 SecretagogueSol (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  2. (diff | hist) 17:09 Placebo-adjusted effect 3,893 ±0 LiraLotte (talk | contribs) add the confidence interval to the point estimate [rollback]
  3. (diff | hist) m 14:10 Injection site rotation 4,064 ±0 ColdChainCleo (talk | contribs) add the sharps-disposal cross-link [rollback]
  4. (diff | hist) 13:19 Electrospray ionisation 3,512 ±0 IsocraticIla (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]
  5. (diff | hist) 11:25 Sigma-Aldrich (Shanghai) Trading 2,963 ±0 FiveOhThreeB (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  6. (diff | hist) m 04:27 Regulatory status by jurisdiction 3,662 +271 Compounding_Cate (talk | contribs) attribute the compounding statement to the pharmacy board that issued it [rollback]
  7. (diff | hist) m 01:50 Reverse-phase HPLC 5,116 +834 Areapercent_Ayo (talk | contribs) split §Principle from §Practical limitations [rollback]

30 April 2025

  1. (diff | hist) 22:12 Loss on drying 3,765 +30 DataTableDunja (talk | contribs) move a stray full stop inside the reference [rollback]
  2. (diff | hist) 21:59 Liraglutide 5,268 +18 A1c_Alder (talk | contribs) clarify that the peptide backbone is acylated rather than PEGylated [rollback]
  3. (diff | hist) 19:11 Aspiration risk under anaesthesia 3,911 +31 RetinopathyRex (talk | contribs) rm the reassurance sentence; the article should report, not reassure [rollback]
  4. (diff | hist) m 11:56 Batch number 3,731 +23 PrimarySrcPatia (talk | contribs) expand §What a batch number cannot do [rollback]
  5. (diff | hist) 11:22 Talk:ChinaPeptides 1,244 +65 Ref_Desk_Ron (talk | contribs) /* Which name should the article title use? */ reply
  6. (diff | hist) 10:40 Talk:Qingdao Sigma Chemical 1,170 +109 PuffRemoverPax (talk | contribs) /* Reporting a tally count without implying a ranking */ reply
  7. (diff | hist) 09:20 Research use only 6,689 ±0 PharmDrafts (talk | contribs) fix the anchor on an internal link [rollback]
  8. (diff | hist) 08:42 Timeline of incretin therapeutics 3,954 ±0 SurvodutideSaff (talk | contribs) the lead claimed weekly dosing for a compound dosed daily; corrected [rollback]
  9. (diff | hist) 02:51 Glossary of peptide terminology 4,611 +40 MolarMassMaeve (talk | contribs) expand §Clinical and evidence [rollback]
  10. (diff | hist) 00:02 Test report forgery 4,203 ±0 CapitalisationCaz (talk | contribs) add the chain-of-custody point to §Limitations [rollback]

29 April 2025

  1. (diff | hist) 17:50 SELECT trial 4,206 ±0 SemaglutideSasha (talk | contribs) ce per PP:MOS [rollback]
  2. (diff | hist) 10:00 CagriSema 4,167 ±0 SurrogateSunday (talk | contribs) consistent en dashes in ranges [rollback]
  3. (diff | hist) 08:52 Talk:Qingdao Sigma Chemical 959 +300 NPOV_Nadia (talk | contribs) /* Reporting a tally count without implying a ranking */ reply
  4. (diff | hist) 04:02 Body composition assessment 4,384 ±0 A1c_Alder (talk | contribs) add the seasonal variation point, sourced [rollback]
  5. (diff | hist) 03:56 Hunan Aslsen Technology 10,064 +1,060 GsCouplingGil (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  6. (diff | hist) 03:15 Custom peptide synthesis 3,777 ±0 SarcopeniaSefa (talk | contribs) move a stray full stop inside the reference [rollback]
  7. (diff | hist) m 02:07 Bacteriostatic water 4,541 +193 DiluentDiya (talk | contribs) de-orphan [rollback]
  8. (diff | hist) 00:37 Insulin syringe unit conversion 4,444 ±0 TSH_Tallulah (talk | contribs) expand §Sources of error [rollback]

28 April 2025

  1. (diff | hist) 20:46 Receptor bias 3,536 ±0 GIP_Genoveva (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) m b 18:49 Sigma-Aldrich (Shanghai) Trading 2,963 +38 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  3. (diff | hist) m b 18:48 Certificate of analysis 8,096 +583 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  4. (diff | hist) m 15:09 Albumin binding half-life extension 4,872 ±0 ReceptorRhoda (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  5. (diff | hist) 13:11 Talk:Qingdao Sigma Chemical 748 +172 TallySheetTad (talk | contribs) /* Reporting a tally count without implying a ranking */ reply
  6. (diff | hist) 11:01 Peptide supply chain 6,954 ±0 DrTitration (talk | contribs) convert the storage conditions to a table [rollback]
  7. (diff | hist) 10:28 Karl Fischer titration 7,300 +91 GradientGus (talk | contribs) ce per PP:MOS [rollback]
  8. (diff | hist) 09:33 Talk:Qingdao Sigma Chemical 537 +233 BalanceBirdie (talk | contribs) /* Reporting a tally count without implying a ranking */ new section
  9. (diff | hist) m 08:34 Customs seizure 3,644 ±0 GreyMarketGreer (talk | contribs) rm the speculation about future scheduling [rollback]

27 April 2025

  1. (diff | hist) 23:28 Peptide aggregation 4,377 ±0 SchematicScout (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  2. (diff | hist) 12:44 Vial filling and stoppering 4,012 ±0 NPOV_Nadia (talk | contribs) state the residual-moisture target with the method it is measured by [rollback]
  3. (diff | hist) m 12:02 Peptide content 6,898 ±0 Areapercent_Ayo (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  4. (diff | hist) 06:21 Lyophilisation 20,900 +873 Chromatokid (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  5. (diff | hist) 04:27 Qingdao Sigma Chemical 10,623 +321 COA_Colwyn (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  6. (diff | hist) 00:53 Preparative HPLC purification 4,562 +696 CoI_Corin (talk | contribs) give the closure integrity test by name [rollback]

26 April 2025

  1. (diff | hist) 20:46 Crude peptide 3,916 ±0 CrudePeptidePearl (talk | contribs) state the difference between a validated shipper and an insulated box [rollback]
  2. (diff | hist) 20:04 Trial data comparison 4,355 +332 BalanceBirdie (talk | contribs) rm the administration advice; the tool computes, it does not instruct [rollback]
  3. (diff | hist) 18:31 Wuhan Wansheng Biotechnology 10,999 +746 TrialsTabitha (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  4. (diff | hist) 16:44 Talk:Sigma-Aldrich (Shanghai) Trading 1,033 +136 ScopeSeverin (talk | contribs) /* A distributor that does not claim manufacture, and what the article may infer from that */ reply
  5. (diff | hist) 16:32 Hubei Jianxiang Bioscience 2,874 ±0 SPPS_Sorrel (talk | contribs) add the reception tally with its period and count stated [rollback]
  6. (diff | hist) 15:17 Oral semaglutide 3,542 ±0 Ref_Desk_Ron (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  7. (diff | hist) 15:08 STEP trial programme 4,391 +34 MassSpecMarv (talk | contribs) state the analysis population: intention-to-treat or per-protocol [rollback]
  8. (diff | hist) m 14:10 VendorInvestigate 4,188 ±0 ClinicCorrespondent (talk | contribs) expand §What it cannot establish [rollback]
  9. (diff | hist) m b 09:47 Bachem Holding (Suzhou) 10,365 +621 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  10. (diff | hist) 05:48 Flourishglobal Peptide Biotech 5,526 +159 FormularyFrida (talk | contribs) attribute the capability claim to the organisation's own material [rollback]